Arye Lipman, founder of the venture capital firm, Mars Bio, recently co-founded LabDAO, an open, community-run network of wet and dry laboratories accelerating progress in the life sciences. Messaginglab founder, Karl Schmieder, sat down with Arye to learn more about decentralized science, LabDAO, and how the world of science might change as people create life science ventures on the blockchain.

I sat down with Ellen to learn more about Aanika Biosciences, Genspace, COVID testing, and the lessons biotech companies could take to increase their storytelling success. What follows are excerpts from our conversation.

Tom Baruch, a seasoned entrepreneur and venture capitalist, began shifting his VC practice from materials science, IT, and biotechnology to the then-nascent field of synthetic biology in 1997. Over the years, he has funded more than 12 synthetic biology companies and has an enviable track record, never losing money and exiting at 5x to double-digits in as little as 18 months.

I sat down with Britni to learn more about K18’s marketing efforts and the lessons emerging biotech companies could take from their storytelling success.